Cannabis
Nimbus and Viva Care Medical Group Health form strategic partnership to offer medical cannabis access via telehealth to patients
Nimbus, an information technology healthcare provider in the medical cannabis industry, and Viva Care Medical Group, a chain of clinics in BC, today announced a strategic partnership to integrate Nimbus’ telehealth offerings within Viva Care clinics and their online presence. This strategic partnership promises to improve access to medical cannabis education and authorizations to patients.
Nimbus will be bringing its secure and state of the art telehealth and education platform to Viva Care patients who are interested in accessing medical cannabis.
“Many family physicians are not yet comfortable with authorizing medical cannabis prescriptions for their patients,” states Nimbus CEO, David Pham. “As we work to help educate physicians, we will concurrently offer telehealth prescribing so that patients can access the cannabis medical treatment that they require.” A survey of physicians in June 2018 by MD Analytics found that only 32% of physicians approved of cannabis legalization.
“Securing this exclusive agreement with Viva Care, a leading health clinic with over 10 locations in British Columbia, will allow for Nimbus to supply an industry leading telehealth solution that meets the growing demand for medicinal cannabis as an alternative and effective treatment offered to patients”, said David Pham, CEO of Nimbus.” Viva Care is also a telehealth care system that relieves patients of the need to travel around to find a suitable physician in obtaining prompt and quality continuous care. We are very excited about our new partnership with Viva Care and look forward to forging many more alliances as we roll out our strategic plan.”
SOURCE GET NIMBUS INC
Cannabis
Sannabis, Inc. (OTC: USPS) Announces First Shipment of Cannabis Essential Oil from Colombia to U.S. to Fill First Order, as the DEA Re-Classifies Marijuana from Schedule I to Schedule III
Cannabis
Technological Advancements in Breathalyzers Drive Market Growth and Enhance Road Safety
Cannabis
Bay Area Social Equity Operator Launches the Purple Raina Balm Wand 1:1, an Inclusive Multipurpose Cannabis Topical
-
Innocan2 weeks ago
Innocan Pharma Initiates FDA Approval Process for Liposome Injection Therapy for Chronic Pain
-
Curaleaf2 weeks ago
Curaleaf Completes Acquisition of Northern Green Canada
-
Cannabis2 weeks ago
Cannabis Capsule Global Analysis Report 2024: Market to Reach $79.2 Billion in 2028 – Forecast to 2033 Featuring GW Pharmaceuticals, Trulieve Cannabis, Green Thumb Industries, Tilray, Columbia Care
-
Cannabis5 days ago
Technological Advancements in Breathalyzers Drive Market Growth and Enhance Road Safety
-
SCHWAZZE6 days ago
Schwazze Sets First Quarter 2024 Conference Call for May 15, 2024 at 5:00 p.m. ET
-
Cannabis5 days ago
Bay Area Social Equity Operator Launches the Purple Raina Balm Wand 1:1, an Inclusive Multipurpose Cannabis Topical
-
Humboldt5 days ago
Humboldt Seed Company partners with Apollo Green to bring California cannabis genetics to the global marketplace
-
Cannabis3 days ago
Sannabis, Inc. (OTC: USPS) Announces First Shipment of Cannabis Essential Oil from Colombia to U.S. to Fill First Order, as the DEA Re-Classifies Marijuana from Schedule I to Schedule III